Equinor ASA ADR (EQNR) concluded trading on Wednesday at a closing price of $27.82, with 4.56 million shares of worth about $126.9 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 21.79% during that period and on June 18, 2025 the price saw a loss of about -0.93%. Currently the company’s common shares owned by public are about 2.73B shares, out of which, 2.73B shares are available for trading.
Stock saw a price change of 7.33% in past 5 days and over the past one month there was a price change of 20.38%. Year-to-date (YTD), EQNR shares are showing a performance of 19.22% which increased to 7.17% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $21.41 but also hit the highest price of $28.26 during that period. The average intraday trading volume for Equinor ASA ADR shares is 3.92 million. The stock is currently trading 10.93% above its 20-day simple moving average (SMA20), while that difference is up 16.52% for SMA50 and it goes to 16.47% higher than SMA200.
Equinor ASA ADR (NYSE: EQNR) currently have 2.73B outstanding shares and institutions hold larger chunk of about 2.67% of that.
The stock has a current market capitalization of $76.07B and its 3Y-monthly beta is at 0.55. PE ratio of stock for trailing 12 months is 8.78, while it has posted earnings per share of $3.17 in the same period. It has Quick Ratio of 1.27 while making debt-to-equity ratio of 0.65. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for EQNR, volatility over the week remained 2.71% while standing at 1.74% over the month.
Stock’s fiscal year EPS is expected to drop by -7.99% while it is estimated to increase by 1.08% in next year. EPS is likely to shrink at an annualized rate of -0.39% for next 5-years, compared to annual growth of 41.31% made by the stock over the past 5-years.
On May 20, 2025, Berenberg Downgrade their recommendations, while on May 12, 2025, Morgan Stanley Downgrade their ratings for the stock with a price target of $22.70. Stock get a Neutral rating from JP Morgan on May 07, 2025.
